WallStSmart
CAPR

Capricor Therapeutics Inc

NASDAQ: CAPR · HEALTHCARE · BIOTECHNOLOGY

$33.58
+3.45% today

Updated 2026-04-30

Market cap
$2.04B
P/E ratio
P/S ratio
124.43x
EPS (TTM)
$-2.26
Dividend yield
52W range
$4 – $40
Volume
1.3M

WallStSmart proprietary scores

31
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D
5.0
Quality
C+
3.0
Profitability
D
8.3
Valuation
A
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$54.67
+62.81%
12-Month target
Intrinsic (DCF)
$55.12
Margin of safety
+56.10%
2 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ 56.10% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-28.69M
- Revenue declining -7.90% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$2.55M$25.18M$22.27M$0.00$11.13M
Net income$-29.02M$-22.29M$-40.47M$-105.04M$-30.17M
EPS$-2.26
Free cash flow$1.56M$-27.64M$-41.53M$-72.72B$-28.69M
Profit margin-1,137.37%-88.52%-181.71%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CAPR$2.04B313.73.08.35.0+56.10%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Capricor Therapeutics Inc trades at $33.58. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $11.13M. Our DCF model estimates intrinsic value at $55.12.

Frequently asked questions

What is Capricor Therapeutics Inc's stock price?
Capricor Therapeutics Inc (CAPR) trades at $33.58.
Is Capricor Therapeutics Inc overvalued?
Smart Value Score 31/100 (Grade F, Strong Sell). DCF value $55.12.
What is the price target of Capricor Therapeutics Inc (CAPR)?
The analyst target price is $54.67, representing +62.8% upside from the current price of $33.58.
What is the intrinsic value of Capricor Therapeutics Inc (CAPR)?
Based on our DCF model, intrinsic value is $55.12, a +56.1% margin of safety versus $33.58.
What is Capricor Therapeutics Inc's revenue?
TTM revenue is $11.13M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio124.43x
ROE-46.60%
Beta0.48
50D MA$30.24
200D MA$17.19
Shares out0.06B
Float0.05B
Short ratio
Avg volume1.3M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years